British Journal of Clinical PharmacologyVolume 6, Issue 6 p. 538-540 Free Access Platelet aggregation and chlorpromazine therapy. DJ Boullin, DJ BoullinSearch for more papers by this authorJM Know, JM KnowSearch for more papers by this authorJR Peters, JR PetersSearch for more papers by this authorMW Orr, MW OrrSearch for more papers by this authorMG Gelder, MG GelderSearch for more papers by this authorDG Grahame-Smith, DG Grahame-SmithSearch for more papers by this author DJ Boullin, DJ BoullinSearch for more papers by this authorJM Know, JM KnowSearch for more papers by this authorJR Peters, JR PetersSearch for more papers by this authorMW Orr, MW OrrSearch for more papers by this authorMG Gelder, MG GelderSearch for more papers by this authorDG Grahame-Smith, DG Grahame-SmithSearch for more papers by this author First published: December 1978 https://doi.org/10.1111/j.1365-2125.1978.tb00881.xCitations: 20AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References Ball, S.E., Boullin, D.J. & Glenton, P.A.M. (1977). Interactions between noradrenaline and 5-hydroxytryptamine involving platelet aggregation. J. Physiol., 272, 98– 99P. Benedict, C.R. & Grahame-Smith, D.G. (1978). Plasma noradrenaline and adrenaline concentrations and dopamine-β-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. Quart. J. Med., New Series 47, 185, 1– 20. Boullin, D.J. & Glenton, P.A.M. (1978) Characterisation of receptors mediating 5-hydroxytryptamine and catecholamine-induced platelet aggregation, assessed by the actions of α and β blockers, butyrophenones, 5-HT antagonists and chlorpromazine. Br. J. Pharmac., 62, 537– 542. Boullin, D.J. & Grimes, R.P.J. (1976). Increased platelet aggregation in patients receiving chlorpromazine: responses to 5-hydroxytryptamine, dopamine and N-dimethyldopamine. Br. J. clin. Pharmac., 3, 649– 654. Boullin, D.J., Orr, M.W. & Peters, J.R. (1978). The platelet as a model for investigating the clinical efficacy of centrally acting drugs: relations between platelet aggregation and clinical condition in patients treated with chlorpromazine. In Platelets: A Multidisciplinary Approach, eds G.S. Gaetano & S. Garattini, New York: Raven Press, (in press). Boullin, D.J., Woods, H.F., Grimes, R.P.J., Grahame-Smith, D.G., Wiles, D., Gelder, M.G. & Kolakowska, T. (1975). Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine. Br. J. clin. Pharmac., 2, 29– 35. Buchsbaum, M.S., Coursey, R.D. & Murphy, D.L. (1976). The biochemical high risk paradigm: behavioural and familial correlates of low platelet monoamine oxidase activity. Science, 194, 339– 341. Mills, D.C.B. & Roberts, G.C.K.(1967). Membrane active drugs and the aggregation of human blood platelets. Nature, 213, 35– 38. Orr, M.W. & Boullin, D.J. (1976). The relationship between changes in 5-HT induced platelet aggregation and clinical state in patients treated with fluphenazine. Br. J. clin. Pharmac., 3, 925– 928. Pletscher, A. (1978). Platelets as models for monoaminergic neurones. In Essays in Neurochemistry and Neuropharmacology, M.B.H. Youdim, W. Lovenberg, D.F. Sharman and J.R. Lagnado eds, pp. 49– 101. Chichester: Wiley. Citing Literature Volume6, Issue6December 1978Pages 538-540 ReferencesRelatedInformation